Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is pituitary gene therapy realistic?

J R Davis1, A S McNeilly

  • 1Endocrine Sciences Research Group, University of Manchester, Manchester, UK. julian.davis@man.ac.uk

Clinical Endocrinology
|October 27, 2001
PubMed
Summary

Gene therapy shows promise for pituitary tumors, overcoming limitations of current treatments. Further research is needed to ensure safety and efficacy before human application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Excess female adrenal androgen secretion is a consequence of in utero androgenic excess in sheep.

Reproduction & fertility·2026
Same author

Circadian clock mechanism driving mammalian photoperiodism.

Nature communications·2020
Same author

Developmental programming of polycystic ovary syndrome (PCOS): prenatal androgens establish pancreatic islet α/β cell ratio and subsequent insulin secretion.

Scientific reports·2016
Same author

Mutation in the protease cleavage site of GDF9 increases ovulation rate and litter size in heterozygous ewes and causes infertility in homozygous ewes.

Animal genetics·2014
Same author

Restoration of ovarian function and natural fertility following the cryopreservation and autotransplantation of whole adult sheep ovaries.

Human reproduction (Oxford, England)·2014
Same author

Npas4 is activated by melatonin, and drives the clock gene Cry1 in the ovine pars tuberalis.

Molecular endocrinology (Baltimore, Md.)·2013

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Gene Therapy

Background:

  • Current pituitary tumor therapies (surgery, radiotherapy, medical) have limitations including poor cure rates and side effects.
  • Dopamine agonist therapy for prolactinomas is ineffective in up to 10% of patients.
  • Gene therapy offers a potential alternative by targeting pituitary cell and molecular biology.

Purpose of the Study:

  • To evaluate the potential of gene therapy for treating pituitary diseases.
  • To assess the efficacy and safety of adenoviral vectors for gene delivery to pituitary cells.

Main Methods:

  • Utilized recombinant adenoviruses for gene delivery due to their ability to transduce pituitary cells.
  • Employed reporter genes (e.g., beta-galactosidase) to assess transgene expression in vitro and in vivo.
  • Demonstrated pituitary cell ablation in cultured cells and subcutaneous tumors in mice.

Main Results:

  • Adenoviral vectors showed high efficiency and long-lasting transgene expression in cultured pituitary cells.
  • In vivo studies demonstrated high-level transgene expression with stereotaxic intrapituitary injection.
  • Pituitary cell ablation was achieved in vitro and in vivo models.

Conclusions:

  • Gene therapy is a feasible future treatment for pituitary diseases.
  • Extensive evaluation of efficacy and safety, including modified vectors to mitigate inflammatory responses, is crucial before human application.
  • Various gene delivery methods require further investigation.

Related Experiment Videos